FindTrial
Sign In

Use of dermal filler injection for inducing drooping of upper lid in patients with corneal exposure resulting from seventh nerve palsy

Use of dermal filler injection for inducing mechanical ptosis in upper lid of patients with exposure keratopathy resulting from facial nerve palsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049176
Enrollment
12
Registered
2023-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H022- Lagophthalmos Health Condition 2: H022- Lagophthalmos Health Condition 3: H022- Lagophthalmos Health Condition 4: H022- Lagophthalmos

Interventions

Intervention1: 0.3 ml of Subdermal injection of dermal filler Gel containing Hyaluronic acid (HA) and lidocaine (Juvederm ultra XC-Allergan) : The above dermal filler injection will be given in up

Sponsors

Command hospital eastern command
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with exposure keratopathy due to facial nerve palsy presenting to eye dept CHEC.

Exclusion criteria

Exclusion criteria: Exposure keratopathy due to other Non Neurogenic cause like Cicatricial Ectropion,Poor blink reflex, Night time lagophthalmos

Design outcomes

Secondary

MeasureTime frame
To determine symptomatic improvement in exposure keratopathy post dermal filler injection Timepoint: day 1 day 3 day 7. 01 month—

Primary

MeasureTime frame
To determine the decrease in lagophthalmos due to induced mechanical ptosis.Timepoint: day 1, day 7, 01 month, 02 months—

Countries

India

Contacts

Public ContactDr Neeraj Sharma

command hospital easterm command kolkata

doc79shimla@gmail.com700406635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026